Top UK scientist to lead Integrative Biology at Liverpool

AnthonyHollander-1wProfessor Hollander was ranked among the top 40 scientists in Britain by The Times, in 2010

The stem cell researcher who was part of the team that successfully created and transplanted the first tissue-engineered windpipe is to head the University of Liverpool’s Institute of Integrative Biology.

Professor Anthony Hollander is currently head of the School of Cellular and Molecular Medicine at the University of Bristol and has more than 20 years of research experience in the fields of cartilage biology, osteoarthritis, stem cells and tissue engineering.  He will succeed Professor Andrew Cossins, who is stepping down in June from his current role as head of the Institute to focus on research and teaching.

In 2008, Professor Hollander and a team of scientists and surgeons successfully created and transplanted the first tissue-engineered trachea (windpipe), using a patient’s own stem cells.

”Professor Hollander’s understanding of the international trends in research and his proven ability to attract funding and partnerships will be invaluable for the strategic direction of the Institute”
In 2010 The Times ranked him 39th in its list of Britain’s 100 most important scientists.

Professor Ian Greer, Provost and Executive Pro-Vice-Chancellor for the Faculty of Health and Life Sciences at Liverpool, said: “Professor Hollander is an exceptional scientist and is a perfect fit for the Institute of Integrative Biology.  His understanding of the international trends in research and his proven ability to attract funding and partnerships will be invaluable for the strategic direction of the Institute.

“I’d like to thank Andrew for his hard work and dedication to the University.”

Professor Hollander who has a PhD in Pathology from the University of Bristol, spent three years at the internationally renowned cartilage laboratory at McGill University in Montreal, before returning to the UK to take up an Arthritis Research UK fellowship and a lectureship at the University of Sheffield.

He has more than 100 publications, with £7 million of peer-reviewed funding over the past 10 years, as well as several patents in his name.  He is co-founder and scientific director of a University of Bristol spin-out company, Azellon Cell Therapeutics.

He said: “I’m very excited to be moving to the University of Liverpool and to be given the opportunity to help shape the future of an important and very successful research institute.”

AnthonyHollander-1h

Leave a comment